Important note

This AI stock analysis for Shattuck Labs is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!

Shattuck Labs - AI Stock Analysis

Analysis generated March 2, 2025

Shattuck Labs is a biopharmaceutical company focusing on novel treatments for cancer and autoimmune diseases. Renowned for their proprietary Agonist Redirected Checkpoint (ARC) platform, Shattuck Labs aims to develop therapies that surpass the limitations of current immunotherapies. The company is dedicated to a pipeline of clinical-stage and preclinical therapies, with strong collaborations in the pharmaceutical industry.

Fundamental Analysis

Revenue for the last quarter was $3M. This is an increase of 86.26% compared to the previous quarter, and a significant year-over-year increase of 336.88%. This demonstrates robust growth and the potential for sustained revenue increments.

Net income for the last quarter stood at $17M. This figure represents an increase of 22.63% from the previous quarter, and a year-over-year increase of 39.45%. The growth in net income highlights the company's improving profitability and operational efficiency.

EBITDA for the last quarter was also $17M. This value showcases an increase of 22.88% quarter-over-quarter, and a substantial year-over-year growth of 38.48%, underscoring effective cost management and enhanced operational performance.

Technical Analysis

Today's stock price is $1.32, reflecting a 13.79% increase compared to a month ago. This indicates a positive short-term trend. However, the price has decreased by 86.32% compared to a year ago, which poses potential for long-term concern.

The trend is currently bullish. The current 10-day Simple Moving Average (SMA10) is $1.43, higher than the previous SMA10 of $1.43. This suggests an upward trend in price movement. Additionally, the Relative Strength Index (RSI) is 25.5, indicative of a potentially oversold bullish condition that may lead to a price rebound.

Alternative Data Analysis

From a staffing perspective, Shattuck Labs has 0 open positions as per popular job boards, indicating stability in current staffing levels. The business outlook among employees is notably high, with 87% expressing a positive outlook, signaling a healthy work environment and strong corporate morale.

However, customer acquisition data reveals that Shattuck Labs has an estimated 2,000 visitors to their webpage, with a decline of 50% over recent months. This downward trend is concerning as it might indicate waning customer interest or outreach.

According to AltIndex’s AI score, which collates fundamental, technical, and alternative data, Shattuck Labs achieves a score of 62, suggesting a buy signal based on its current evaluations.

Conclusion and Recommendation

In conclusion, Shattuck Labs demonstrates strong fundamental financial health with a significant increase in both revenue and net income, indicating robust growth and effective cost management. The technical indicators are mixed, with a positive short-term bullish trend offset by long-term stock price decline. Alternative data points to stable employee sentiment but highlights concerns with customer acquisition trends.

Given the comprehensive analysis, it appears that Shattuck Labs presents both opportunities and risks. Investors should consider these factors within their broader investment strategy and risk tolerance.

It is advisable for investors to conduct further due diligence and to potentially consult with a financial advisor before making any investment decisions regarding Shattuck Labs.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.